Filing Details
- Accession Number:
- 0000950170-25-093302
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-02 17:50:11
- Reporting Period:
- 2025-06-30
- Filing Date:
- 2025-07-02
- Accepted Time:
- 2025-07-02 17:50:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652130 | Intellia Therapeutics Inc. | NTLA | In Vitro & In Vivo Diagnostic Substances (2835) | 364785571 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1756929 | Jesse Goodman | C/O Intellia Therapeutics, Inc. 40 Erie Street; Suite 130 Cambridge MA 02139 | No | No | No | No |
Transaction Summary
| Sold: | 3,094 shares | Avg. Price: $9.40 | Total Value: $29,068.13 |
| Number of Shares After Transactions: | 24,359 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-30 | 1,547 | $9.56 | 25,906 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 1,547 | $9.23 | 24,359 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reported sale of 3,094 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 31, 2025.
Billionaire Hedge Funds
